951656-23-8

Basic information

• Product Name: trans-3-[2-(3,4,5-trimethoxybenzoyl)benzofuran-5-yl]acrylic acid tert-butyl ester
• Synonyms: trans-3-[2-(3,4,5-trimethoxybenzoyl)benzofuran-5-yl]acrylic acid tert-butyl ester
• CAS NO: 951656-23-8
• Molecular Weight: 438.477
• Mol File: 951656-23-8.mol

Chemical Properties

• CAS DataBase Reference: trans-3-[2-(3,4,5-trimethoxybenzoyl)benzofuran-5-yl]acrylic acid tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: trans-3-[2-(3,4,5-trimethoxybenzoyl)benzofuran-5-yl]acrylic acid tert-butyl ester(951656-23-8)
• EPA Substance Registry System: trans-3-[2-(3,4,5-trimethoxybenzoyl)benzofuran-5-yl]acrylic acid tert-butyl ester(951656-23-8)

Safety Data

• Hazardous Substances Data: 951656-23-8(Hazardous Substances Data)

Upstream product

• 3328-70-9 5-formyl-2-hydroxybenzaldehyde 
• 51490-01-8 1-(3,4,5-trimethoxyphenyl)-2-bromoethanone 
• 951656-20-5 2-(3,4,5-trimethoxybenzoyl)benzofuran-5-carbaldehyde 
• 35000-37-4 (tert-butyloxycarbonylmethyl)triphenylphosphonium chloride 

Downstream Products

• 951656-29-4 trans-N-(tetrahydropyran-2-yloxy)-3-[2-(3,4,5-trimethoxybenzoyl)benzofuran-5-yl]acrylamide 

Relevant articles and documents

2-Aroylindoles and 2-aroylbenzofurans with N-hydroxyacrylamide substructures as a novel series of rationally designed histone deacetylase inhibitors

Histone deacetylase (HDAC) inhibitors are considered to be drugs for targeted cancer therapy and second-generation HDIs are currently being tested in clinical trials. Here, we report on the synthesis and biological evaluation of a novel HDAC inhibitor sca